Acrivon Therapeutics (ACRV) Return on Capital Employed [ROCE] (2022 - 2026)
Acrivon Therapeutics' Return on Capital Employed [ROCE] came in at -85.17% for Q2 2026, down 23.89 percentage points from -61.29% a year earlier and down 8.72 percentage points from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Return on Capital Employed [ROCE] (2022 - 2026) Analysis & Trends
For FY2025, Acrivon Therapeutics' Return on Capital Employed [ROCE] was -57.03%, up 2.35 percentage points from FY2024.
- Return on Capital Employed [ROCE] carries a three-year change of -33.26 percentage points (FY2022 to FY2025).
- Going back by year, Return on Capital Employed [ROCE] was -59.38% in FY2024 (-13.56 pp), -45.82% in FY2023 (-22.05 pp) and -23.77% in FY2022.
- The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2022.
- Year-over-year, Return on Capital Employed [ROCE] has declined for five consecutive quarters, with an average year-over-year change of -12.66 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2025 (a gain of 4.58 percentage points), and the weakest in Q1 2024 (a drop of 35.05 percentage points).
- Business Quant data shows ACRV's Return on Capital Employed [ROCE] at -76.45% (Q1 2026), -69.03% (Q4 2025) and -64.90% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Acrivon Therapeutics | 85.27 Mn | 85.27 Mn | - | -85.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -85.17% |
| Mar 31, 2026 | -76.45% |
| Dec 31, 2025 | -69.03% |
| Sep 30, 2025 | -64.90% |
| Jun 30, 2025 | -61.29% |
| Mar 31, 2025 | -53.89% |
| Dec 31, 2024 | -47.34% |
| Sep 30, 2024 | -41.05% |
| Jun 30, 2024 | -46.45% |
| Mar 31, 2024 | -58.48% |
| Dec 31, 2023 | -51.08% |
| Sep 30, 2023 | -38.28% |
| Jun 30, 2023 | -31.27% |
| Mar 31, 2023 | -23.43% |
| Dec 31, 2022 | -25.52% |
API Access
Acrivon Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();